Docebo Inc. (DCBO) Stock Forecast
Data as of Aug 1, 2026Technology · Current price $20.55 (-1.25%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | Robert Young | Canaccord Genuity | $36.00 | +75.2% |
| Mar 2, 2026 | George Sutton | Craig-Hallum | $38.00 | +84.9% |
| Jan 29, 2026 | Ken Wong | Oppenheimer | $25.00 | +21.6% |
| Jan 21, 2026 | Matthew VanVliet | Cantor Fitzgerald | $28.00 | +36.2% |
| Nov 5, 2025 | Ken Wong | Oppenheimer | $35.00 | +70.3% |
| Apr 16, 2025 | Josh Baer | Morgan Stanley | $41.00 | +99.5% |
| Oct 24, 2024 | Kevin Krishnaratne | Scotiabank | $55.00 | +167.6% |
| Sep 16, 2024 | Kevin Kumar | Goldman Sachs | $48.00 | +133.6% |
| Sep 12, 2024 | Ryan MacDonald | Needham | $50.00 | +143.3% |
| Aug 9, 2024 | Robert Young | Canaccord Genuity | $54.00 | +162.8% |
| Jun 7, 2024 | George Sutton | Craig-Hallum | $58.00 | +182.2% |
| May 14, 2024 | Robert Young | Canaccord Genuity | $55.00 | +167.6% |
| May 14, 2024 | Kevin Krishnaratne | Scotiabank | $50.00 | +143.3% |
| Nov 14, 2023 | Ryan MacDonald | Needham | $56.00 | +172.5% |
| Aug 18, 2023 | Josh Baer | Morgan Stanley | $49.00 | +138.4% |
| Aug 13, 2021 | Brett Knoblauch | Cantor Fitzgerald | $82.00 | +299.0% |
Top Analysts Covering DCBO
DCBO vs Sector & Market
| Metric | DCBO | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.36 | 2.42 |
| Analyst Count | 6 | 14 | 19 |
| Target Upside | +68.6% | +1710.8% | +18.0% |
| P/E Ratio | 17.37 | 37.66 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $68M | $68M | $69M | 4 |
| 2026-12-31 | $70M | $70M | $71M | 4 |
| 2027-03-31 | $70M | $71M | $72M | 4 |
| 2027-06-30 | $73M | $73M | $74M | 3 |
| 2027-09-30 | $75M | $76M | $77M | 3 |
| 2027-12-31 | $78M | $78M | $79M | 3 |
| 2028-12-31 | $330M | $332M | $334M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.42 | $0.43 | $0.43 | 1 |
| 2026-12-31 | $0.46 | $0.47 | $0.48 | 2 |
| 2027-03-31 | $0.37 | $0.37 | $0.38 | 2 |
| 2027-06-30 | $0.42 | $0.43 | $0.43 | 1 |
| 2027-09-30 | $0.47 | $0.48 | $0.48 | 1 |
| 2027-12-31 | $0.54 | $0.55 | $0.56 | 2 |
| 2028-12-31 | $2.42 | $2.44 | $2.46 | 1 |
Frequently Asked Questions
What is the analyst consensus for DCBO?
The consensus among 6 analysts covering Docebo Inc. (DCBO) is Buy with an average price target of $31.80.
What is the highest price target for DCBO?
The highest price target for DCBO is $82.00, set by Brett Knoblauch at Cantor Fitzgerald on 2021-08-13.
What is the lowest price target for DCBO?
The lowest price target for DCBO is $25.00, set by Ken Wong at Oppenheimer on 2026-01-29.
How many analysts cover DCBO?
6 analysts have issued ratings for Docebo Inc. in the past 12 months.
Is DCBO a buy or sell right now?
Based on 6 analyst ratings, DCBO has a consensus rating of Buy (2.17/5) with a +68.6% upside to the consensus target of $31.80.
What are the earnings estimates for DCBO?
Analysts estimate DCBO will report EPS of $0.43 for the period ending 2026-09-30, with revenue estimated at $68M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.